Identification of Enriched Driver Gene Alterations in Subgroups of Non-Small Cell Lung Cancer Patients Based on Histology and Smoking Status
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of Enriched Driver Gene Alterations in Subgroups of Non-Small Cell Lung Cancer Patients Based on Histology and Smoking Status
Authors
Keywords
-
Journal
PLoS One
Volume 7, Issue 6, Pages e40109
Publisher
Public Library of Science (PLoS)
Online
2012-06-30
DOI
10.1371/journal.pone.0040109
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role of LKB1 in lung cancer
- (2011) Montse Sanchez-Cespedes Familial Cancer
- Molecular Selection Trumps Clinical Selection
- (2011) Frances A. Shepherd JOURNAL OF CLINICAL ONCOLOGY
- Clinical Characteristics of Patients With Lung Adenocarcinomas HarboringBRAFMutations
- (2011) Paul K. Paik et al. JOURNAL OF CLINICAL ONCOLOGY
- Relative Abundance of EGFR Mutations Predicts Benefit From Gefitinib Treatment for Advanced Non–Small-Cell Lung Cancer
- (2011) Qing Zhou et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular biomarkers in non-small-cell lung cancer: a retrospective analysis of data from the phase 3 FLEX study
- (2011) Kenneth J O'Byrne et al. LANCET ONCOLOGY
- New driver mutations in non-small-cell lung cancer
- (2011) William Pao et al. LANCET ONCOLOGY
- Smoking history and lung carcinoma: KRAS mutation is an early hit in lung adenocarcinoma development
- (2011) F.B. Thunnissen et al. LUNG CANCER
- Mutations in the DDR2 Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer
- (2011) Peter S. Hammerman et al. Cancer Discovery
- LKB1 in lung cancerigenesis: a serine/threonine kinase as tumor suppressor
- (2011) Yijun Gao et al. Protein & Cell
- East meets West: ethnic differences in epidemiology and clinical behaviors of lung cancer between East Asians and Caucasians
- (2011) Wei Zhou et al. Chinese Journal of Cancer
- Identifying cancer driver genes in tumor genome sequencing studies
- (2010) Ahrim Youn et al. BIOINFORMATICS
- Driver mutations and differential sensitivity to targeted therapies: a new approach to the treatment of lung adenocarcinoma
- (2010) Giuseppe Bronte et al. CANCER TREATMENT REVIEWS
- Genetic profiling and epidermal growth factor receptor-directed therapy in nonsmall cell lung cancer
- (2010) J. Cadranel et al. EUROPEAN RESPIRATORY JOURNAL
- Lung Adenocarcinoma From East Asian Never-Smokers Is a Disease Largely Defined by Targetable Oncogenic Mutant Kinases
- (2010) Yihua Sun et al. JOURNAL OF CLINICAL ONCOLOGY
- KRAS and BRAF: drug targets and predictive biomarkers
- (2010) Efsevia Vakiani et al. JOURNAL OF PATHOLOGY
- Frequency of EGFR and KRAS Mutations in Japanese Patients with Lung Adenocarcinoma with Features of the Mucinous Subtype of Bronchioloalveolar Carcinoma
- (2010) Akito Hata et al. Journal of Thoracic Oncology
- Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression
- (2010) Xuchao Zhang et al. Molecular Cancer
- Rapidly Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in NSCLC Cell Lines through De-Repression of FGFR2 and FGFR3 Expression
- (2010) Kathryn E. Ware et al. PLoS One
- Clinicopathologic Features of Non-Small-Cell Lung Cancer with EML4–ALK Fusion Gene
- (2009) Tsuyoshi Takahashi et al. ANNALS OF SURGICAL ONCOLOGY
- Histologic Considerations for Individualized Systemic Therapy Approaches for the Management of Non-small Cell Lung Cancer
- (2009) Howard West et al. CHEST
- Nonsmall cell lung cancer in never smokers
- (2009) Giorgio V Scagliotti et al. CURRENT OPINION IN ONCOLOGY
- Advances in Target Therapy for Lung Cancer
- (2009) T. Mitsudomi JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Clinical outcome of patients with non-small cell lung cancer receiving front-line chemotherapy according to EGFR and K-RAS mutation status
- (2009) Aristea Kalikaki et al. LUNG CANCER
- KRAS mutations and resistance to EGFR-TKIs treatment in patients with non-small cell lung cancer: A meta-analysis of 22 studies
- (2009) Chen Mao et al. LUNG CANCER
- Are RAS mutations predictive markers of resistance to standard chemotherapy?
- (2009) Yohann Loriot et al. Nature Reviews Clinical Oncology
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
- (2009) Tony S. Mok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinicopathologic and Molecular Features of Epidermal Growth Factor Receptor T790M Mutation and c-MET Amplification in Tyrosine Kinase Inhibitor-resistant Chinese Non-small Cell Lung Cancer
- (2009) Hua-Jun Chen et al. PATHOLOGY & ONCOLOGY RESEARCH
- High-Resolution Melting Analysis for Rapid Detection ofKRAS, BRAF,andPIK3CAGene Mutations in Colorectal Cancer
- (2008) Lisa Simi et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- EML4-ALK Fusion Is Linked to Histological Characteristics in a Subset of Lung Cancers
- (2008) Kentaro Inamura et al. Journal of Thoracic Oncology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started